ONCY News and Press, Oncolytics Biotech Inc. From 12/15/21

Palm Beach, FL – December 15, 2021 – FinancialNewsMedia.com News Commentary – Acute Myeloid Leukemia (AML) is a type of blood cancer which usually affects white blood cells (WBCs), however, it can also start in other types of blood-forming cells. In AML, the...

Oncolytics Biotech® Announces the Presentation of Preclinical Data Demonstrating the Synergistic Anti-Leukemic Effects of Pelareorep Combined with Azacitidine at the 2021 American Society of Hematology Annual Meeting Canada NewsWire - Treatment with intravenous pe...

FN Media Group Presents USA News Group News Commentary Vancouver, BC –December 10, 2021 – USA News Group –  Researchers led by a scholar from City University of Hong Kong (CityU) have developed a novel artificial intelligence (AI) framework ...

Palm Beach, FL – December 10, 2021 – FinancialNewsMedia.com News Commentary – Ongoing advancements in cancer research continue to lead to the introduction of newer and better treatment options including drug therapies. The provision of newer drugs and treatm...

Oncolytics Biotech (NASDAQ:ONCY) gains 9.2% premarket after announcing a positive interim safety update from phase 2 IRENE trial at the 2021 San Antonio Breast Cancer Symposium (SABCS). The IRENE trial is designed to evaluate the safety and efficacy of pelareorep in combination with...

Oncolytics Biotech® Presents Positive Interim Safety Update from Phase 2 Triple-Negative Breast Cancer Trial at the 2021 San Antonio Breast Cancer Symposium Canada NewsWire - No safety concerns have been noted in any trial participants - Trial builds on pr...

FN Media Group Presents USA News Group News Commentary Vancouver, BC –December 8, 2021 – USA News Group –  Growing at a healthy CAGR of 14.1%, the Cancer Immunotherapy Market is being projected to hit nearly $310 billion by 2030, according to ...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

Oncolytics Biotech® to Present Phase 2 Triple-Negative Breast Cancer Trial Update at the 2021 San Antonio Breast Cancer Symposium Canada NewsWire IRENE study is evaluating pelareorep-anti-PD-1 combination treatment in metastatic TNBC SAN DIEGO and ...

Oncolytics Biotech Inc. (ONCY) Q3 2021 Earnings Conference Call November 5, 2021 08:00 ET Company Participants Jon Patton - Director of Investor Relations & Communications Matt Coffey - President, Chief Executive Officer & Director Tom Heineman - Global Head of Clinical Development &a...